Asthma and COPD Drugs Market size was over USD 40.5 billion in 2024 and is anticipated to exceed USD 105.44 billion by the end of 2037, witnessing over 7.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of asthma and COPD drugs is evaluated at USD 43.03 billion. The market growth is due to the increasing prevalence of respiratory diseases.
The industry includes a variety of drugs, including bronchodilators, corticosteroids, combination therapies, and monoclonal antibodies. Furthermore, there have been surging investments in drugs, and therapy by competitors for the cure of diseases in order to have a competitive advantage.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?